- Home
- NTZ vs LPCN Comparison
NTZ vs LPCN Comparison
Compare NTZ & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- LPCN
- Stock Information
- Founded
- NTZ 1959
- LPCN 1997
- Country
- NTZ Italy
- LPCN United States
- Employees
- NTZ N/A
- LPCN N/A
- Industry
- NTZ Home Furnishings
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- LPCN Health Care
- Exchange
- NTZ Nasdaq
- LPCN Nasdaq
- Market Cap
- NTZ 45.4M
- LPCN 36.8M
- IPO Year
- NTZ 1993
- LPCN N/A
- Fundamental
- Price
- NTZ $4.00
- LPCN $4.94
- Analyst Decision
- NTZ
- LPCN Strong Buy
- Analyst Count
- NTZ 0
- LPCN 1
- Target Price
- NTZ N/A
- LPCN $10.00
- AVG Volume (30 Days)
- NTZ 3.0K
- LPCN 30.8K
- Earning Date
- NTZ 11-26-2024
- LPCN 11-07-2024
- Dividend Yield
- NTZ N/A
- LPCN N/A
- EPS Growth
- NTZ N/A
- LPCN N/A
- EPS
- NTZ N/A
- LPCN N/A
- Revenue
- NTZ $351,353,263.00
- LPCN $7,922,926.00
- Revenue This Year
- NTZ N/A
- LPCN N/A
- Revenue Next Year
- NTZ N/A
- LPCN N/A
- P/E Ratio
- NTZ N/A
- LPCN N/A
- Revenue Growth
- NTZ N/A
- LPCN N/A
- 52 Week Low
- NTZ $3.80
- LPCN $2.38
- 52 Week High
- NTZ $7.20
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- NTZ 43.96
- LPCN 44.02
- Support Level
- NTZ $4.01
- LPCN $4.79
- Resistance Level
- NTZ $4.33
- LPCN $5.40
- Average True Range (ATR)
- NTZ 0.16
- LPCN 0.54
- MACD
- NTZ -0.01
- LPCN -0.12
- Stochastic Oscillator
- NTZ 0.00
- LPCN 16.01
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.